Loading…
National Biodefense Strategy Act of 2016
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
86pct
99d open
vs 3,548 other S bills in the 114th — cohort avg 43d
National Biodefense Strategy Act of 2016 (Sec. 2) This bill amends the Homeland Security Act of 2002 to direct the President to: develop, submit, and periodically update a National Biodefense Strategy to direct and align federal efforts toward an effective and continuously improving biodefense enterprise, including threat awareness, prevention and protection, surveillance and detection, and response and recovery to major biological incidents; establish a Biodefense Coordination Council to provide the expertise necessary to develop the strategy and which shall align government biodefense activities and spending in a manner consistent with the strategy; and report annually on total federal agency expenditures on biodefense activities and how the expenditures relate to strategy goals and priorities. The strategy shall serve as a comprehensive guide for U.S. biodefense and shall include: a comprehensive description of the entities and leadership positions responsible for implementing, overseeing, and coordinating federal biodefense activities; five-year goals, priorities, and metrics to improve and strengthen the government's ability to prevent, detect, respond to, and recover from a major biological incident; research and development projects or initiatives planned to improve biodefense capability; and recommendations for legislative action. The strategy shall also include an appendix, which shall contain: a review of collaborative efforts between the Armed Forces and the civilian sector of the government on biodefense activities and coordination; and a detailed analyses of recommendations issued by external biodefense review commissions, lessons learned from the government response to public health emergencies within the preceding five years, major biological incident risks, resources and capabilities needed to address identified risks, resource and capability gaps in the biodefense enterprise, and prioritization and allocation of investment across the biodefense enterprise.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2016 · fourth_quarter · Homeland Security
Legislative issues regarding homeland security H.R.4909/S.2943, National Defense Authorization Act of 2017 S.2967, National Biodefense Strategy Act of 2016
Client expense: Not reported · Firm income: $20,000
Placed on Senate Legislative Calendar under General Orders. Calendar No. 577.
Committee on Homeland Security and Governmental Affairs. Reported by Senator Johnson under authority of the order of the Senate of 07/14/2016 with amendments and an amendment to the title. With written report No. 114-306.
Committee on Homeland Security and Governmental Affairs. Ordered to be reported with amendments favorably.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE
2016 · fourth_quarter · Homeland Security
Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2017 (P.L. 114-254)- provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 5634 and S. 3001 - Department of Homeland Security Appropriations Act, 2017 (P.L. 114-254)- provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 4909 and S. 2943 - National Defense Authorization Act for Fiscal Year 2017 (P.L. 114-328)- Section 1086 - National Biodefense Strategy; and provisions related to chemical decontamination; H.R. 5293 and S. 3000 - Department of Defense Appropriations Act, 2017 (P.L. 114-254)- provisions related to chemical decontamination and Ebola response and preparedness; H.R. 1300 and S. 1915 - First Responder Anthrax Preparedness Act (P.L. 114-268)- entire bill relating to anthrax vaccines for emergency response providers; H.R. 3299 - Strengthening Public Health Emergency Response Act of 2016 (P.L. 114-255)- entire bill reforming federal preparedness for biothreats; S. 2967 - National Biodefense Strategy Act of 2016 - entire bill improving coordination of programs and resources for biological public health emergencies.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Disaster Planning/Emergencies
Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2017 (P.L. 114-254)- provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 5634 and S. 3001 - Department of Homeland Security Appropriations Act, 2017 (P.L. 114-254)- provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 4909 and S. 2943 - National Defense Authorization Act for Fiscal Year 2017 (P.L. 114-328)- Section 1086 - National Biodefense Strategy; and provisions related to chemical decontamination; H.R. 5293 and S. 3000 - Department of Defense Appropriations Act, 2017 (P.L. 114-254)- provisions related to chemical decontamination and Ebola response and preparedness; H.R. 1300 and S. 1915 - First Responder Anthrax Preparedness Act (P.L. 114-268)- entire bill relating to anthrax vaccines for emergency response providers; H.R. 3299 - Strengthening Public Health Emergency Response Act of 2016 (P.L. 114-255)- entire bill reforming federal preparedness for biothreats; S. 2967 - National Biodefense Strategy Act of 2016 - entire bill improving coordination of programs and resources for biological public health emergencies.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Homeland Security
Biodefense Research, Development and Procurement Issues (Nonfunding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2967: National Biodefense Strategy Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika
Client expense: $2,330,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of Technology Policy (OTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Vice President of the U.S.
2016 · third_quarter · Health Issues
340B Drug Pricing Program ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---Implementation of Affordable Care Act ---Program Implementation & Oversight Antibiotic & Diagnostic Tax Credit ---H.R. 3539: Antibiotic & Diagnostic Innovation Act Biodefense Research, Development and Procurement Issues (Nonfunding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2967: National Biodefense Strategy Act Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorizaton and Implementation ---Interchangeability and Pharmacy Substitution ---Naming ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 Drug Evaluation and Review ---ADAPT Act (House Discussion Draft) ---Compassionate Use/Expanded Access ---FDA Proposed Rule on Changes to Drug Labeling ---H.R. 2029: The Patient Choice Act ---H.R. 4475: Compassionate Freedom of Choice Act ---Implementation of the FDA Safety and Innovation Act ---Reauthorization of the Prescription Drug User Fee Act ---S. 2912: Trickett Wendler Right to Try Act of 2016 ---Special Medical Use/Limited Population Drugs Drug Importation ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Drug Manufacturing, Quality & Distribution ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Implementation of H.R. 3204: The Drug Quality and Security Act ---Pharmacy Compounding & Oversight ---Vial and Dose Size Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Centers for Disease Control and Prevention Vaccine Programs ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for FDA ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Gene Editing Technologies ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Generic Drug Entry ---S. 2615: Increasing Competition in Pharmaceuticals Act ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 Government Price Reporting ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Medicaid Pricing and Rebates ---Average Manufacturer Price Calculations ---Implementation of Affordable Care Act Reimbursement for Innovative Products ---CMMI Medicare Part B Proposed Demonstration Project ---H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare Part B Prescription Drug Models ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Value-based Contracting and Communications Senate Innovation for Healthier Americans ---Biomarkers and Regulatory Science Improvements ---Communication with Healthcare Professionals and Payors ---Expanded Access to Investigational Drugs ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---H.R. 4762: Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act ---Innovation Incentives ---Longitudinal Study of Chronic Diseases ---Patient Access to Approved Drugs ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---S. 195: PATH Act ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2912: Trickett Wendler Right to Try Act of 2016 ---S.524: Comprehensive Addiction and Recovery Act of 2016 ---The KIDS Act ---Use of Real-World Evidence ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---S. 1878: Advancing Hope Act of 2015 ---S.2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act Transatlantic Trade and Investment Partnership ---Intellectual Property Issues ---Regulatory Harmonization TransPacific Partnership ---Data and Intellectual Property Protection for Pharmaceuticals Vaccine Access/Financing ---Adult Immunization (Senate Discussion Draft) ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---Implementation of Affordable Care Act ---Senate Chronic Care Working Group Proposals Vaccines and Infectious Diseases - General ---S.2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act ---H.R. 5325: Continuing appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Orphan Drug Tax Credit Independent Payment Advisory Board UN High Level Commission on Access to Medicines ---Intellectual Property Provisions Sunshine Act Implementation Precision Medicine Initiative Affordable Care Act Implementation ---Third Party Support of Patient Premiums and Cost-Sharing Obligations
Client expense: $2,330,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of Technology Policy (OTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Vice President of the U.S.
2016 · third_quarter · Medical/Disease Research/Clinical Labs
Biodefense Research, Development and Procurement Issues (Nonfunding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2967: National Biodefense Strategy Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Gene Editing Technologies ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Senate Innovation for Healthier Americans ---Longitudinal Study of Chronic Diseases Precision Medicine Initiative
Client expense: $2,330,000 · Firm income: Not reported
2016 · third_quarter · Disaster Planning/Emergencies
Draft - Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 5634 and S. 3001 - Department of Homeland Security Appropriations Act - 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 4909 and S. 2943 - National Defense Authorization Act for Fiscal Year 2017 - provisions related to chemical decontamination; H.R. 5293 and S. 3000 - Department of Defense Appropriations Act, 2017 - provisions related to chemical decontamination and Ebola response and preparedness; H.R. 1300 and S. 1915 - First Responder Anthrax Preparedness Act - entire bill relating to anthrax vaccines for emergency response providers; H.R. 3299 - Strengthening Public Health Emergency Response Act of 2016 - entire bill reforming federal preparedness for biothreats; S. 2967 - National Biodefense Strategy Act of 2016 - entire bill improving coordination of programs and resources for biological public health emergencies.
Client expense: Not reported · Firm income: $45,000
2016 · third_quarter · Homeland Security
Draft - Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 5634 and S. 3001 - Department of Homeland Security Appropriations Act - 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines; H.R. 4909 and S. 2943 - National Defense Authorization Act for Fiscal Year 2017 - provisions related to chemical decontamination; H.R. 5293 and S. 3000 - Department of Defense Appropriations Act, 2017 - provisions related to chemical decontamination and Ebola response and preparedness; H.R. 1300 and S. 1915 - First Responder Anthrax Preparedness Act - entire bill relating to anthrax vaccines for emergency response providers; H.R. 3299 - Strengthening Public Health Emergency Response Act of 2016 - entire bill reforming federal preparedness for biothreats; S. 2967 - National Biodefense Strategy Act of 2016 - entire bill improving coordination of programs and resources for biological public health emergencies.
Client expense: Not reported · Firm income: $45,000
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of Technology Policy (OTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Vice President of the U.S.
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE